Brian D. Kent

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma

Joanne Kavanagh, A Hearn, Jaideep Dhariwal et al. · CHEST Journal · 2020 · 260 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Diabetes Mellitus Prevalence and Control in Sleep-Disordered Breathing

Brian D. Kent, Ludger Grote, Jean‐Louis Pépin et al. · CHEST Journal · 2014 · 237 citations

Medicine, Endocrinology, Internal Medicine +14

Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma

Joanne Kavanagh, G d’Ancona, Maria Elstad et al. · CHEST Journal · 2020 · 204 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation

Aoife M. Murphy, Amandine Thomas, Sophie J. Crinion et al. · European Respiratory Journal · 2017 · 186 citations · Full text

Medicine, Endocrinology, Physiology +17

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

David J. Jackson, Liam G. Heaney, Marc Humbert et al. · The Lancet · 2023 · 139 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14